本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ARS PHARMACEUTICALS INC

4.15
-0.0150-0.36%
盤後4.10-0.0500-1.20%19:40 EDT
成交量:187.32萬
成交額:779.40萬
市值:4.13億
市盈率:-1.91
高:4.30
開:4.26
低:4.12
收:4.17
52周最高:13.15
52周最低:4.12
股本:9,944.73萬
流通股本:4,803.45萬
量比:0.93
換手率:3.90%
股息:- -
股息率:- -
每股收益(TTM):-2.1757
每股收益(LYR):-1.7400
淨資產收益率:-210.35%
總資產收益率:-48.02%
市淨率:32.98
市盈率(LYR):-2.39

資料載入中...

2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/17

重要事件披露

Form 8-K - Current report
2026/07/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/07

重要事件披露

Form 8-K - Current report
2026/06/25

重要事件披露

Form 8-K - Current report